Healthcare suppliers and lab employees utilizing Illumina genetic sequencing devices are suggested to right away patch the machine software program in opposition to a brand new vulnerability that the Meals and Drug Administration says might put sufferers in peril.
Affected units embody Illumina NextSeq 550Dx, MiSeqDx, NextSeq 500, NextSeq 550, MiSeq, iSeq, and MiniSeq next-generation sequencing devices, the FDA mentioned.
The medical units are used to check for genetic circumstances and genetic sequencing, and the FDA mentioned the bug, first detected on Might 3, could possibly be exploited by menace actors to take over the Illumina devices. That might enable them to alter the working system, entry a buyer’s community, tamper with take a look at outcomes, and even steal information. The flaw impacts the Native Run Supervisor software program, the FDA added.
Up to now, there are not any experiences of the bug being exploited, the FDA mentioned in a cybersecurity alert to well being care suppliers; nevertheless, the company asks “customers to report any adversarial occasions or suspected adversarial occasions skilled with Illumina’s next-generation sequencing devices.”
